Rise Advisors »

Global X Fds genomic biotech shares owned by Rise Advisors

Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Rise Advisors from 13F filings

Historical chart of Rise Advisors investment in Global X Fds genomic biotech

Tip: Access up to 7 years of quarterly data

All positions including Global X Fds genomic biotech held by Rise Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global X Fds genomic biotech by Rise Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.7k 500 11.38
2023-12-31 $5.8k 500 11.56
2023-09-30 $5.1k 500 10.17
2023-06-30 $6.1k 500 12.12

More positions owned by Rise Advisors

Vanguard Growth Etf 0 (VUG)
Vanguard Value Etf 0 (VTV)
Dimensional Core Fixed Income Etf 0 (DFCF)
Janus Henderson Mortgage-backed Securities Etf 0 (JMBS)
Janus Henderson Short Duration Income Etf 0 (VNLA)
Dimensional U.s. Targeted Value Etf 0 (DFAT)
Financial Select Sector Spdr Fund 0 (XLF)
Industrial Select Sector Spdr Fund 0 (XLI)
Wisdomtree Emerging Markets Ex-state-owned Enterprises Fund 0 (XSOE)
Paypal Hldgs 0 (PYPL)
Nvidia Corporation 0 (NVDA)
Microsoft Corp 0 (MSFT)
Amazon 0 (AMZN)
Berkshire Hathaway Inc Del Cl B 0 (BRK.B)
Alphabet Inc Cap Stk Cl C 0 (GOOG)

View all positions for Rise Advisors

Top funds holding Global X Fds genomic biotech

Jane Street
One Capital Management
Mirae Asset Global Investments
Lido Advisors
Raymond James Financial Services Advisors
UBS Group
Stratos Wealth Partners
Sightline Wealth Advisors
McGuire Investment Group
Berson & Corrado Investment Advisors
Prosperity Wealth Management
Manhattan West Asset Management
HighTower Advisors
Banco Santander
Archford Capital Strategies

View all funds holding Global X Fds genomic biotech